The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Janssen Research & Development
Pivotal phase 2 MonumenTAL-1 results of talquetamab (tal), a GPRC5DxCD3 bispecific antibody (BsAb), for relapsed/refractory multiple myeloma (RRMM).
 
Carolina D. Schinke
Honoraria - Janssen
Consulting or Advisory Role - Janssen
Research Funding - Janssen
 
Cyrille Touzeau
Honoraria - Janssen
Consulting or Advisory Role - Janssen Biotech
Travel, Accommodations, Expenses - Janssen
 
Monique C. Minnema
Consulting or Advisory Role - CDR-life (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst)
Speakers' Bureau - Celgene/Bristol-Myers Squibb (Inst); Janssen medical Affairs (Inst); Medscape (Inst)
Research Funding - BeiGene (Inst)
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Celgene; GlaxoSmithKline; H3 Biomedicine; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; BMS; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Speakers' Bureau - BMS; GlaxoSmithKline; Janssen; Sanofi
Travel, Accommodations, Expenses - Pfizer
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Leo Rasche
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb; Skyline Diagnostics
 
Jing Christine Ye
Honoraria - BMS; Janssen Scientific Affairs
Consulting or Advisory Role - BMS; Janssen
Research Funding - Celgene (Inst); Genmab (Inst); GlaxoSmithKline (Inst); MingSight (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst)
 
Deeksha Vishwamitra
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Xuewen Ma
Employment - Johnson & Johnson/Janssen; Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Xiang Qin
Employment - Janssen Research & Development
 
Michela Campagna
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Tara J. Masterson
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Brandi Hilder
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen
 
Jaszianne A. Tolbert
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Research Funding - Janssen Research & Development
 
Thomas Renaud
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson and Johnson
 
Jenna Goldberg
Employment - Janssen; Vividion Therapeutics
Leadership - Vividion Therapeutics
Stock and Other Ownership Interests - Johnson & Johnson
Patents, Royalties, Other Intellectual Property - JNJ
 
Christoph Heuck
No Relationships to Disclose
 
Ajai Chari
Consulting or Advisory Role - Abbvie; Amgen; Antengene; Bristol-Myers Squibb/Celgene; Genentech; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; OncoPeptides; Seagen; Secura Bio; Shattuck Labs; Takeda
Research Funding - Amgen; Celgene; Janssen; Pharmacyclics; Seagen; Takeda